Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 Ann Intern Med
3 Antiviral Res
10 BMJ
3 Clin Infect Dis
9 Emerg Infect Dis
4 Int J Infect Dis
1 Intensive Care Med
1 Invest Radiol
1 J Infect
11 J Med Virol
1 J Virol
1 Lancet
2 Lancet Infect Dis
1 N Engl J Med
2 Nature

    Ann Intern Med

  1. SERCHEN J, Cline K, Mathew S, Hilden D, et al
    Preparing for Future Pandemics and Public Health Emergencies: An American College of Physicians Policy Position Paper.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/M23-0768.
    >> Share

    Antiviral Res

  2. BOWDEN-REID E, Ledger S, Zhang Y, Di Giallonardo F, et al
    Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.
    Antiviral Res. 2023 Jul 19:105677. doi: 10.1016/j.antiviral.2023.105677.
    >> Share

  3. SUPREWICZ L, Szczepanski A, Lenart M, Piktel E, et al
    Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response.
    Antiviral Res. 2023 Jul 20:105676. doi: 10.1016/j.antiviral.2023.105676.
    >> Share

  4. SPENGLER JR, Carter K, Delang L, Durantel D, et al
    Meeting report: 36th international conference on antiviral research in Lyon, France, March 13-17, 2023.
    Antiviral Res. 2023 Jul 24:105678. doi: 10.1016/j.antiviral.2023.105678.
    >> Share


  5. ANDERSSON NW, Thiesson EM, Baum U, Pihlstrom N, et al
    Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged >/=50 years in Nordic countries: nationwide cohort study.
    BMJ. 2023;382:e075286.
    >> Share

  6. ANDERSSON NW, Thiesson EM, Baum U, Pihlstrom N, et al
    Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.
    BMJ. 2023;382:e074325.
    >> Share

  7. ESTABROOKS CA, Ewa V, Keefe J, Straus SE, et al
    The predictable crisis of covid-19 in Canada's long term care homes.
    BMJ. 2023;382:e075148.
    >> Share

  8. MISHRA S, Walker JD, Wilhelm L, Lariviere V, et al
    Use and misuse of research: Canada's response to covid-19 and its health inequalities.
    BMJ. 2023;382:e075666.
    >> Share

  9. BUBELA T, Flood CM, McGrail K, Straus SE, et al
    How Canada's decentralised covid-19 response affected public health data and decision making.
    BMJ. 2023;382:e075665.
    >> Share

  10. ANDERSON M, MacKinnon M
    We can learn from the covid-19 pandemic management strategy of First Nations communities in Canada.
    BMJ. 2023;382:p1675.
    >> Share

  11. HOUSTON AR, Liu J, Habibi R, Murthy S, et al
    Canada's role in covid-19 global vaccine equity failures.
    BMJ. 2023;382:e075149.
    >> Share

  12. ANDERSSON NW, Thiesson EM, Hansen JV, Hviid A, et al
    Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study.
    BMJ. 2023;382:e075015.
    >> Share

  13. Why older adults can continue to benefit from covid-19 boosters.
    BMJ. 2023;382:p1662.
    >> Share

  14. AL-ORAIBI A, Woolf K, Fatimah S, Pareek M, et al
    Healthcare workers must be included in long covid research in the UK.
    BMJ. 2023;382:p1721.
    >> Share

    Clin Infect Dis

  15. POZZI C, Sarti R, Levi R, Mollura M, et al
    Association between duration of SARS-CoV-2 positivity and long COVID.
    Clin Infect Dis. 2023 Jul 22:ciad434. doi: 10.1093.
    >> Share

  16. HASSANZADEH H, Baber J, Begier E, Noriega DC, et al
    Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STRIVE Randomized Clinical Trial.
    Clin Infect Dis. 2023 May 1:ciad218. doi: 10.1093.
    >> Share

  17. CHUNG H, Campitelli MA, Buchan SA, Campigotto A, et al
    Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults.
    Clin Infect Dis. 2023 Mar 21:ciad148. doi: 10.1093.
    >> Share

    Emerg Infect Dis

  18. YOO BK, Iwamoto R, Chung U, Sasaki T, et al
    Economic Evaluation of Wastewater Surveillance Combined with Clinical COVID-19 Screening Tests, Japan.
    Emerg Infect Dis. 2023;29:1608-1617.
    >> Share

  19. MANGIONI D, Chatenoud L, Colombo J, Palomba E, et al
    Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients(1).
    Emerg Infect Dis. 2023;29:1598-1607.
    >> Share

  20. MCMANUS O, Christiansen LE, Nauta M, Krogsgaard LW, et al
    Predicting COVID-19 Incidence Using Wastewater Surveillance Data, Denmark, October 2021-June 2022.
    Emerg Infect Dis. 2023;29:1589-1597.
    >> Share

  21. TOOMRE D, Kandula S, Shaman J
    Longitudinal Association of COVID-19 Hospitalization and Death with Online Search for Loss of Smell or Taste.
    Emerg Infect Dis. 2023;29:1711-1713.
    >> Share

  22. HECHT G, Dale AP, Ruberto I, Adame G, et al
    Detection of Hantavirus during the COVID-19 Pandemic, Arizona, USA, 2020.
    Emerg Infect Dis. 2023;29:1663-1667.
    >> Share

  23. FALENDER RA, Mitchell PG, Guzman-Cottrill JA, Cieslak PR, et al
    Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020-June 30, 2022.
    Emerg Infect Dis. 2023;29:1672-1675.
    >> Share

  24. KUSAMA T, Takeuchi K, Tamada Y, Kiuchi S, et al
    Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020-2022.
    Emerg Infect Dis. 2023;29.
    >> Share

  25. TSANG TK, Huang X, Fong MW, Wang C, et al
    Effects of School-Based Preventive Measures on COVID-19 Incidence, Hong Kong, 2022.
    Emerg Infect Dis. 2023;29.
    >> Share

  26. ATHERSTONE CJ, Guagliardo SAJ, Hawksworth A, O'Laughlin K, et al
    COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020-2021.
    Emerg Infect Dis. 2023;29.
    >> Share

    Int J Infect Dis

  27. LIANG W, Lv H, Chen C, Sun Y, et al
    Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season - a serological study using retrospective samples collected in Hong Kong.
    Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00659.
    >> Share

  28. AGUARELES J, Villares-Fernandez P, Carralon-Gonzalez MM, Forne C, et al
    Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
    Int J Infect Dis. 2023 Jul 21:S1201-9712(23)00661.
    >> Share

  29. FANG X, Lu K, Sun S, Zhang H, et al
    Infection caused by Cupriavidus gilardii in a convalescent COVID-19 patient.
    Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00663.
    >> Share

  30. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

    Intensive Care Med

  31. ARABI YM, Diaz J, Lamontagne F
    Coronavirus disease 2019.
    Intensive Care Med. 2023 Jul 28. doi: 10.1007/s00134-023-07168.
    >> Share

    Invest Radiol

  32. HENAO JAG, Depotter A, Bower DV, Bajercius H, et al
    A Multiclass Radiomics Method-Based WHO Severity Scale for Improving COVID-19 Patient Assessment and Disease Characterization From CT Scans.
    Invest Radiol. 2023 Jul 27. doi: 10.1097/RLI.0000000000001005.
    >> Share

    J Infect

  33. PIERANGELI A, Nenna R, Fracella M, Scagnolari C, et al
    Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome.
    J Infect. 2023 Jul 24:S0163-4453(23)00381-X. doi: 10.1016/j.jinf.2023.
    >> Share

    J Med Virol

  34. ROY A, Saade C, Josset L, Clement B, et al
    Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.
    J Med Virol. 2023;95:e28984.
    >> Share

  35. CHEN Y, Liu X, Tong Z
    Can inspiratory muscle training benefit patients with COVID-19? A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28956.
    >> Share

  36. ZENG G, Li J, Wang L, Zhang Z, et al
    Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital.
    J Med Virol. 2023;95:e28988.
    >> Share

  37. Correction to "Long-Term Risk of Herpes Zoster Following Covid-19: A Retrospective Cohort Study of 2 442 686 Patients".
    J Med Virol. 2023;95:e28944.
    >> Share

  38. QU Y, Wang W, Xiao MZX, Zheng Y, et al
    The interplay between lipid droplets and virus infection.
    J Med Virol. 2023;95:e28967.
    >> Share

  39. Correction to "Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: a systematic review and meta-analysis of randomized control trials".
    J Med Virol. 2023;95:e28916.
    >> Share

  40. Correction to "SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2".
    J Med Virol. 2023;95:e28935.
    >> Share

  41. AUGUSTINE G, Sisila V, Indhu M, Gupta D, et al
    Redirecting the JAK-STAT signal blocks the SARS-CoV-2 replication.
    J Med Virol. 2023;95:e28965.
    >> Share

  42. VISOS-VARELA I, Zapata-Cachafeiro M, Pintos-Rodriguez S, Bugarin-Gonzalez R, et al
    Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.
    J Med Virol. 2023;95:e28971.
    >> Share

  43. SHARIQ M, Malik AA, Sheikh JA, Hasnain SE, et al
    Regulation of autophagy by SARS-CoV-2: The multifunctional contributions of ORF3a.
    J Med Virol. 2023;95:e28959.
    >> Share

  44. WATANABE A, Malik A, Aikawa T, Briasoulis A, et al
    Extracorporeal membrane oxygenation for COVID-19-associated acute respiratory distress syndrome: A nationwide analysis.
    J Med Virol. 2023;95:e28961.
    >> Share

    J Virol

  45. SHARMA M, Chakravarty D, Hussain A, Zalavadia A, et al
    Ifit2 restricts murine coronavirus spread to the spinal cord white matter and its associated myelin pathology.
    J Virol. 2023 Jul 28:e0074923. doi: 10.1128/jvi.00749.
    >> Share


  46. SURAN M
    HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID's Mental Health Symptoms.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13605.
    >> Share

  47. HARRIS E
    Free COVID-19 Vaccinations on the Way for Uninsured Adults.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
    >> Share


  48. O'BRIEN KL, Lemango E
    The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
    Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
    >> Share

    Lancet Infect Dis

  49. MATEO-URDIALES A, Sacco C, Fotakis EA, Del Manso M, et al
    Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study.
    Lancet Infect Dis. 2023 Jul 18:S1473-3099(23)00374.
    >> Share

  50. MADHI SA, Feikin DR
    Are bivalent vaccines better than ancestral-virus monovalent vaccines in protecting against severe omicron COVID-19?
    Lancet Infect Dis. 2023 Jul 18:S1473-3099(23)00425.
    >> Share

    N Engl J Med

  51. BECERRA X, Jha A
    Project NextGen - Defeating SARS-CoV-2 and Preparing for the Next Pandemic.
    N Engl J Med. 2023 Jul 26. doi: 10.1056/NEJMp2307867.
    >> Share


  52. PETRIC HOWE N, Bundell S
    AI-enhanced night-vision lets users see in the dark.
    Nature. 2023 Jul 26. doi: 10.1038/d41586-023-02424.
    >> Share

    Meet the scientists planning for disasters.
    Nature. 2023;619:S1-S3.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016